Hello, this is the MediBloc team.
Great news as MediBloc in Korea expand its actual medical expense insurance simple claim service to patients at Guro Sungsim Medical Center(hereafter ‘GS Medical Center’).
In July 2022, MediBloc in Korea successfully completed the partnership between GS Medical Center and Medipass. Those who go to GS Medical Center can easily retrieve their medical history data from Medipass through simple identification and connection with GS Medical Center’s medical history records. In addition, patients can use the Pass Claim Plus service that allows patients of this hospital to claim actual medical expense insurance in the app, without documents, from 40 insurance companies in Korea.
GS Medical Center is a general hospital that operates 16 medical departments, burn centers, and special clinics with a total of 202 beds. It consists of about 30 specialists with abundant clinical experience covering internal medicine and surgery, neurosurgery, and orthopedics, and is establishing an efficient surgical system through cooperation with other medical fields. In addition, examinations conducted at general hospitals are made possible, examination results are quickly checked, and a treatment link system for diseases is established. It also provides integrated nursing care services that nursing personnel handle 24 hours a day and provide customized treatment services for complex elderly diseases. GS Medical Center’s main priority is its patient-centered philosophy, providing comfortable and efficient treatment services to patients.
MediBloc in Korea CEO Dr. Eunsol Lee said, “I am happy to successfully link GS Medical Center and Medipass. It is expected that all patients at GS Medical Center can check their medical details and claim their insurance easily through the Medipass app. In the future, we will try to create a model case of a medical ecosystem where patients safely manage and use medical information.”
We are happy to expand Medipass’s linked hospital. We will continue to actively attract cooperative medical institutions and companies and expand our platform. Thank you for your continued interest and support.
